Loading...
Bumetanide for autism: Open‐label trial in six children
AIM: Bumetanide, a diuretic agent, that reduces intracellular chloride—thereby reinforcing GABAergic inhibition—has been reported to improve core symptoms of autism in children. Given the positive results reported from French trials of bumetanide in children with autism, we decided to evaluate its e...
Na minha lista:
| Udgivet i: | Acta Paediatr |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248373/ https://ncbi.nlm.nih.gov/pubmed/33336381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apa.15723 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|